Most Alzheimer's disease and nearly half of all dementia was associated with variations in the APOE gene, a study of 470,000 older adults suggested. In all-cause dementia, the two alleles were linked ...

Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope's strategic focus on early, actionable dementia detection. ROCKVILLE, ...

Explore the latest advancements in Alzheimer’s drug research, revealing hope for earlier diagnosis and new treatment options.

"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...

While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating ...

During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and aid clinical testing.

Scientists are searching for the secret in Doug Whitney’s biology that has protected him from dementia, hoping it could lead to ways to treat or prevent Alzheimer’s for many other people. Doug Whitney ...

Alzheimer’s disease, which represents 60–80% of dementia cases 1, robs people of their memory, cognition and independence. A decade-long period of mild cognitive impairment precedes the onset of ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...

Doctors categorize Alzheimer’s according to when it develops and which areas of your brain are affected. Researchers are also discovering different cellular patterns that may eventually be used to ...